KETOROLAC, PREGABALIN
IJB-KEPREST-2022
Phase 2 small_molecule active
Quick answer
KETOROLAC, PREGABALIN for Estrogen receptor-positive early breast cancer (ER + BC). is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Estrogen receptor-positive early breast cancer (ER + BC).
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active